Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Sakaida

Showing results (51-60 of 332) with videos related to

Pageof 34
Sort By:
The American Journal of Case Reports|November 19, 2019
Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case ReportTakuya Iwamoto, Issei Saeki, Isao Hidaka, et al.
Liver|December 3, 2002
Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinomaHitoshi Shirahashi, Isao Sakaida, Shuji Terai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 24, 2002
Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen alpha2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-betaMakoto Segawa, Kozo Kayano, Eiki Sakaguchi, et al.
Journal of Gastroenterology|May 11, 2020
Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)Isao Sakaida, Shuji Terai, Masayuki Kurosaki, et al.
Biochemical and Biophysical Research Communications|March 12, 2004
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined dietKotaro Kawaguchi, Isao Sakaida, Masako Tsuchiya, et al.
World Journal of Gastroenterology|September 14, 2016
Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionTaro Takami, Takahiro Yamasaki, Issei Saeki, et al.
Biochemical and Biophysical Research Communications|September 29, 2011
Senescence marker protein 30 (SMP30)/regucalcin (RGN) expression decreases with aging, acute liver injuries and tumors in zebrafishKoichi Fujisawa, Shuji Terai, Yoshikazu Hirose, et al.
Hepato-Gastroenterology|March 30, 2011
Does chromoendoscopy improve the colonoscopic adenoma detection rate?Kazuo Hashimoto, Shingo Higaki, Makoto Nishiahi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 8, 2002
Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the ratYohei Fukumoto, Fujio Murakami, Aiko Tateishi, et al.
Biochemical and Biophysical Research Communications|May 7, 2003
L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activationTakashi Horie, Isao Sakaida, Fumihiko Yokoya, et al.
Pageof 34

Showing results (51-60 of 332) with videos related to

Sort By:
Pageof 34
The American Journal of Case Reports|November 19, 2019
Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case ReportTakuya Iwamoto, Issei Saeki, Isao Hidaka, et al.
Liver|December 3, 2002
Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinomaHitoshi Shirahashi, Isao Sakaida, Shuji Terai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 24, 2002
Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen alpha2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-betaMakoto Segawa, Kozo Kayano, Eiki Sakaguchi, et al.
Journal of Gastroenterology|May 11, 2020
Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)Isao Sakaida, Shuji Terai, Masayuki Kurosaki, et al.
Biochemical and Biophysical Research Communications|March 12, 2004
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined dietKotaro Kawaguchi, Isao Sakaida, Masako Tsuchiya, et al.
World Journal of Gastroenterology|September 14, 2016
Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionTaro Takami, Takahiro Yamasaki, Issei Saeki, et al.
Biochemical and Biophysical Research Communications|September 29, 2011
Senescence marker protein 30 (SMP30)/regucalcin (RGN) expression decreases with aging, acute liver injuries and tumors in zebrafishKoichi Fujisawa, Shuji Terai, Yoshikazu Hirose, et al.
Hepato-Gastroenterology|March 30, 2011
Does chromoendoscopy improve the colonoscopic adenoma detection rate?Kazuo Hashimoto, Shingo Higaki, Makoto Nishiahi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 8, 2002
Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the ratYohei Fukumoto, Fujio Murakami, Aiko Tateishi, et al.
Biochemical and Biophysical Research Communications|May 7, 2003
L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activationTakashi Horie, Isao Sakaida, Fumihiko Yokoya, et al.
Pageof 34